c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro L Marconcini, S Marchiò, L Morbidelli, E Cartocci, A Albini, M Ziche, ... Proceedings of the National Academy of Sciences 96 (17), 9671-9676, 1999 | 389 | 1999 |
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3 A Salameh, AK Lee, M Cardó-Vila, DN Nunes, E Efstathiou, FI Staquicini, ... Proceedings of the National Academy of Sciences 112 (27), 8403-8408, 2015 | 285 | 2015 |
Overexpression of the RON gene in human breast carcinoma P Maggiora, S Marchio, MC Stella, M Giai, A Belfiore, MD Bortoli, ... Oncogene 16 (22), 2927-2933, 1998 | 267 | 1998 |
Ligand-targeted theranostic nanomedicines against cancer VJ Yao, S D'Angelo, KS Butler, C Theron, TL Smith, S Marchiò, ... Journal of Controlled Release 240, 267-286, 2016 | 222 | 2016 |
Aminopeptidase A is a functional target in angiogenic blood vessels S Marchiò, J Lahdenranta, RO Schlingemann, D Valdembri, P Wesseling, ... Cancer cell 5 (2), 151-162, 2004 | 161 | 2004 |
Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells S Marchio, L Primo, M Pagano, G Palestro, A Albini, T Veikkola, I Cascone, ... Journal of Biological Chemistry 274 (39), 27617-27622, 1999 | 133 | 1999 |
The combination of sorafenib and everolimus abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models Y Pignochino, C Dell'Aglio, M Basiricò, F Capozzi, M Soster, S Marchiò, ... Clinical Cancer Research 19 (8), 2117-2131, 2013 | 126 | 2013 |
Identification of CD36 molecular features required for its in vitro angiostatic activity L Primo, C Ferrandi, C Roca, S Marchiò, L Di Blasio, M Alessio, ... The FASEB journal 19 (12), 1713-1715, 2005 | 105 | 2005 |
Luminescent silica nanoparticles for cancer diagnosis W Arap, R Pasqualini, M Montalti, L Petrizza, L Prodi, E Rampazzo, ... Current medicinal chemistry 20 (17), 2195-2211, 2013 | 96 | 2013 |
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma M Loi, S Marchiò, P Becherini, D Di Paolo, M Soster, F Curnis, C Brignole, ... Journal of controlled release 145 (1), 66-73, 2010 | 89 | 2010 |
BCAM and LAMA5 mediate the recognition between tumor cells and the endothelium in the metastatic spreading of KRAS-mutant colorectal cancer A Bartolini, S Cardaci, S Lamba, D Oddo, C Marchiò, P Cassoni, ... Clinical cancer research 22 (19), 4923-4933, 2016 | 86 | 2016 |
SERS active Ag nanoparticles in mesoporous silicon: detection of organic molecules and peptide–antibody assays A Virga, P Rivolo, E Descrovi, A Chiolerio, G Digregorio, F Frascella, ... Journal of Raman Spectroscopy 43 (6), 730-736, 2012 | 76 | 2012 |
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer M Parri, L Pietrovito, A Grandi, S Campagnoli, E De Camilli, F Bianchini, ... Angiogenesis 17, 881-896, 2014 | 66 | 2014 |
Cell surface–associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein S Marchio, M Alfano, L Primo, D Gramaglia, L Butini, L Gennero, ... Blood 105 (7), 2802-2811, 2005 | 63 | 2005 |
Emerging pharmacologic targets in cerebral cavernous malformation and potential strategies to alter the natural history of a difficult disease: a review MO Chohan, S Marchiò, LA Morrison, RL Sidman, WK Cavenee, ... JAMA neurology 76 (4), 492-500, 2019 | 57 | 2019 |
A complex of α6 integrin and E‐cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin‐like 6 S Marchio, M Soster, S Cardaci, A Muratore, A Bartolini, V Barone, ... EMBO molecular medicine 4 (11), 1156-1175, 2012 | 56 | 2012 |
Targeted dual-color silica nanoparticles provide univocal identification of micrometastases in preclinical models of colorectal cancer M Soster, R Juris, S Bonacchi, D Genovese, M Montalti, E Rampazzo, ... International Journal of Nanomedicine, 4797-4807, 2012 | 56 | 2012 |
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings M Loi, D Di Paolo, M Soster, C Brignole, A Bartolini, L Emionite, J Sun, ... Journal of controlled release 170 (2), 233-241, 2013 | 54 | 2013 |
Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer F Ferrara, DI Staquicini, WHP Driessen, S D’Angelo, AS Dobroff, M Barry, ... Proceedings of the National Academy of Sciences 113 (45), 12786-12791, 2016 | 53 | 2016 |
Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors E Dondossola, AS Dobroff, S Marchiò, M Cardó-Vila, H Hosoya, SK Libutti, ... Proceedings of the National Academy of Sciences 113 (8), 2223-2228, 2016 | 50 | 2016 |